-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, OgblX5VPvyX1ab/NYOd0KX4wF2sdihRQiU2n6q91cZvjI0jDMBwQayqs8E2Cealw 3xQALC1F7G1BJYedRXAAjg== 0001127602-10-010882.txt : 20100409 0001127602-10-010882.hdr.sgml : 20100409 20100409172448 ACCESSION NUMBER: 0001127602-10-010882 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20100401 FILED AS OF DATE: 20100409 DATE AS OF CHANGE: 20100409 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Davies Angela M. CENTRAL INDEX KEY: 0001488772 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15190 FILM NUMBER: 10743345 MAIL ADDRESS: STREET 1: OSI PHARMACEUTICALS, INC. STREET 2: 41 PINELAWN RD. CITY: MELVILLE STATE: NY ZIP: 11747 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OSI PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000729922 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 133159796 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 41 PINELAWN ROAD CITY: MELVILLE STATE: NY ZIP: 11747 BUSINESS PHONE: 631-962-2000 MAIL ADDRESS: STREET 1: 41 PINELAWN ROAD CITY: MELVILLE STATE: NY ZIP: 11747 FORMER COMPANY: FORMER CONFORMED NAME: ONCOGENE SCIENCE INC DATE OF NAME CHANGE: 19920703 3 1 form3.xml PRIMARY DOCUMENT X0203 3 2010-04-01 0 0000729922 OSI PHARMACEUTICALS INC OSIP 0001488772 Davies Angela M. C/O OSI PHARMACEUTICALS, INC. 41 PINELAWN ROAD MELVILLE NY 11747 1 Sr. VP and CMO, Oncology Common Stock 5718 D Stock Option (Right to Buy) 38.13 2009-03-03 2015-03-02 Common Stock 18900 D Stock Option (Right to Buy) 33.62 2009-12-16 2015-12-15 Common Stock 2580 D Stock Option (Right to Buy) 35.40 2010-12-15 2019-12-14 Common Stock 9000 D Consists of (i) 743 shares of Common Stock and (ii) 4,975 Restricted Stock Units, which vest over a period of 4 years from their respective dates of grant. Dr. Davies will receive one share of OSI Common Stock upon the vesting of each Restricted Stock Unit. 25% of the option became exerciseable one year after the date of grant and the remainder will vest ratably on an annual basis over the succeeding 3 years. 25% of the option will become exerciseable one year after the date of grant and the remainder will vest ratably on an annual basis over the succeeding 3 years. Includes only options with the same termination date. Exhibit List: Exhibit 24--Power of Attorney /s/ Pierre Legault, attorney-in-fact for Dr. Davies 2010-04-09 EX-24 2 doc1.txt POWER OF ATTORNEY LIMITED POWER OF ATTORNEY Know all by these presents that the undersigned hereby constitutes and appoints Pierre Legault with full power of substitution and re-substitution, the undersigned's true and lawful attorney-in-fact to: (1) execute for and on behalf of the undersigned, in the undersigned's capacity as an officer and/or director of OSI Pharmaceuticals, Inc. (the "Company") Forms 3, 4, and 5 in accordance with Section 16(a) of the Securities Act of 1934, and the rules thereunder: (2) do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, Form 4 or Form 5, complete and execute any amendment or amendments thereto, and timely file such form with the United States Securities and Exchange Commission and any stock exchange or similar authority; and (3) take any other action of any type whatsoever in connection with the foregoing which in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney in fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion. The undersigned hereby grants to each such attorney- in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorneys-in-fact substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934. This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4 and 5 with respect to the undersigned's holdings of, and transactions in securities issued by the Company unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact. IN WITNESS WHEREOF, the undersigned has executed this Power of Attorney as of this 7th day of April, 2010. By: /s/ Angela M. Davies -----END PRIVACY-ENHANCED MESSAGE-----